CONTENTS
Contents
5. 6.
Chapter 1: Outsourcing supply operations
Integrating new technologies for temperature-sensitive supply chains Why innovation to improve temperature-sensitive shipments is on TSafe’s agenda
8.
3D printing in drug manufacturing: unlocking future possibilities
How 3D printing has potential in the democratisation of drug access
12.
A retrospective of the COVID-19 pandemic and its effect on clinical trials Abacus Medicine Pharma Services reflects on the challenges of COVID-19
14.
US Pharmacopeia report finds high reliance on Indian manufacturers for APIs The ongoing dependency on overseas manufacturers
16.
Just-in-time: on schedule to rescue the clinical trial supply chain? The benefits of just-in-time to clinical trials amid global supply chain pressures
20.
Risk management of clinical trial supplies Clinical Services International on sourcing comparator or co-medication in clinical trials
46.
23. 24.
Chapter 2: Technology and innovation
Injectable opportunities for CMOs despite internal capacity of big pharma sponsors Why companies are turning to outsourcing to meet market demand for injectables
26.
Continuous manufacturing builds on hype but adoption remains gradual The drive towards continuous manufacturing
4 | Clinical Trial Supply Handbook 37. 30.
IRT in clinical trials; what to add to your shopping list Essential advice on finding the right provider of IRT software solutions
33. 34.
Chapter 3: Supply and logistics
Navigating delivery and access challenges for rare disease drugs How specialty pharmacies and value-based contracts could shape niche drug distribution
A perfect storm: pandemic adds further burden to CAR-T development The continued impact of COVID-19 across the CAR T-cell therapy industry
39.
Cutting the carbon footprint of pharma’s supply chain Tackling carbon emissions means targeting the whole value chain
43. 44.
Chapter 4: Future supply models
Breaking silos will be key in future- proofing clinical trial supply chains Why future-proofing means getting the data, innovation and governance right
Direct to patient: the rocky road to remote drug delivery in clinical trials The opportunities in sending investigational drugs directly to study participants
49.
Insulin pricing: could an e-commerce approach cut costs? Electronic selling could mitigate spiralling insulin prices
52. Suppliers’ directory
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56
